You are here

  • Home
  • Archive
  • Volume 79, Issue 9
  • Efficacity of a sequential treatment by anti-CD 20 monoclonal antibody and belimumab in type II cryoglobulinaemia associated with primary Sjögren syndrome refractory to rituximab alone

Citation Tools

Article menu
Download PDFPDF
Letter
Efficacity of a sequential treatment by anti-CD 20 monoclonal antibody and belimumab in type II cryoglobulinaemia associated with primary Sjögren syndrome refractory to rituximab alone

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Chevalier K, Belkhir R, Seror R, et al
Efficacity of a sequential treatment by anti-CD 20 monoclonal antibody and belimumab in type II cryoglobulinaemia associated with primary Sjögren syndrome refractory to rituximab alone
Annals of the Rheumatic Diseases 2020;79:1257-1259.